Cargando…
Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil
So far, deep repetitive transcranial magnetic stimulation (drTMS) has shown promising results as an add-on treatment for Parkinson’s disease (PD) but not for non-idiopathic Parkinson Syndromes (PS). We aimed to investigate the safety and feasibility of drTMS application in patients with different Pa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783590/ https://www.ncbi.nlm.nih.gov/pubmed/36548187 http://dx.doi.org/10.3390/neurolint14040082 |
_version_ | 1784857613561757696 |
---|---|
author | Cont, Celine Lehto, Annaliis Stute, Nathalie Galli, Anastasia Schulte, Christina Deer, Veronika Wessler, Michaela Wojtecki, Lars |
author_facet | Cont, Celine Lehto, Annaliis Stute, Nathalie Galli, Anastasia Schulte, Christina Deer, Veronika Wessler, Michaela Wojtecki, Lars |
author_sort | Cont, Celine |
collection | PubMed |
description | So far, deep repetitive transcranial magnetic stimulation (drTMS) has shown promising results as an add-on treatment for Parkinson’s disease (PD) but not for non-idiopathic Parkinson Syndromes (PS). We aimed to investigate the safety and feasibility of drTMS application in patients with different Parkinson Syndromes and medical refractory symptoms. Multifaceted real-world data (n = 21) were retrospectively analyzed regarding adverse effects as well as short-term effects of the drTMS treatment on patients’ self-rated symptom severity and motor, cognitive, and emotional functions. The drTMS treatment with H5 coil included a sequential 1 Hz primary motor cortex stimulation contralateral to the more-affected body side and a bilateral 10 Hz stimulation of the prefrontal cortex. Overall, drTMS could be safely administered to patients with different PSs and medical refractory symptoms, but large variation was apparent in the rate and severity ratings of the reported adverse event/adverse device effect. The treatment significantly decreased the subjective main symptom severity. This effect was more pronounced in older patients with PD. Furthermore, analysis showed an improvement in depression, but no effect could be established in terms of cognitive performance. drTMS can be safely administered to patients with PS and medical refractory symptoms and can decrease the subjective motor symptom severity and depression. |
format | Online Article Text |
id | pubmed-9783590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97835902022-12-24 Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil Cont, Celine Lehto, Annaliis Stute, Nathalie Galli, Anastasia Schulte, Christina Deer, Veronika Wessler, Michaela Wojtecki, Lars Neurol Int Article So far, deep repetitive transcranial magnetic stimulation (drTMS) has shown promising results as an add-on treatment for Parkinson’s disease (PD) but not for non-idiopathic Parkinson Syndromes (PS). We aimed to investigate the safety and feasibility of drTMS application in patients with different Parkinson Syndromes and medical refractory symptoms. Multifaceted real-world data (n = 21) were retrospectively analyzed regarding adverse effects as well as short-term effects of the drTMS treatment on patients’ self-rated symptom severity and motor, cognitive, and emotional functions. The drTMS treatment with H5 coil included a sequential 1 Hz primary motor cortex stimulation contralateral to the more-affected body side and a bilateral 10 Hz stimulation of the prefrontal cortex. Overall, drTMS could be safely administered to patients with different PSs and medical refractory symptoms, but large variation was apparent in the rate and severity ratings of the reported adverse event/adverse device effect. The treatment significantly decreased the subjective main symptom severity. This effect was more pronounced in older patients with PD. Furthermore, analysis showed an improvement in depression, but no effect could be established in terms of cognitive performance. drTMS can be safely administered to patients with PS and medical refractory symptoms and can decrease the subjective motor symptom severity and depression. MDPI 2022-12-12 /pmc/articles/PMC9783590/ /pubmed/36548187 http://dx.doi.org/10.3390/neurolint14040082 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cont, Celine Lehto, Annaliis Stute, Nathalie Galli, Anastasia Schulte, Christina Deer, Veronika Wessler, Michaela Wojtecki, Lars Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil |
title | Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil |
title_full | Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil |
title_fullStr | Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil |
title_full_unstemmed | Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil |
title_short | Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil |
title_sort | safety of deep repetitive transcranial magnetic stimulation (drtms) against medical refractory symptoms in parkinson syndromes: first german real-world data with a specific h5 coil |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783590/ https://www.ncbi.nlm.nih.gov/pubmed/36548187 http://dx.doi.org/10.3390/neurolint14040082 |
work_keys_str_mv | AT contceline safetyofdeeprepetitivetranscranialmagneticstimulationdrtmsagainstmedicalrefractorysymptomsinparkinsonsyndromesfirstgermanrealworlddatawithaspecifich5coil AT lehtoannaliis safetyofdeeprepetitivetranscranialmagneticstimulationdrtmsagainstmedicalrefractorysymptomsinparkinsonsyndromesfirstgermanrealworlddatawithaspecifich5coil AT stutenathalie safetyofdeeprepetitivetranscranialmagneticstimulationdrtmsagainstmedicalrefractorysymptomsinparkinsonsyndromesfirstgermanrealworlddatawithaspecifich5coil AT gallianastasia safetyofdeeprepetitivetranscranialmagneticstimulationdrtmsagainstmedicalrefractorysymptomsinparkinsonsyndromesfirstgermanrealworlddatawithaspecifich5coil AT schultechristina safetyofdeeprepetitivetranscranialmagneticstimulationdrtmsagainstmedicalrefractorysymptomsinparkinsonsyndromesfirstgermanrealworlddatawithaspecifich5coil AT deerveronika safetyofdeeprepetitivetranscranialmagneticstimulationdrtmsagainstmedicalrefractorysymptomsinparkinsonsyndromesfirstgermanrealworlddatawithaspecifich5coil AT wesslermichaela safetyofdeeprepetitivetranscranialmagneticstimulationdrtmsagainstmedicalrefractorysymptomsinparkinsonsyndromesfirstgermanrealworlddatawithaspecifich5coil AT wojteckilars safetyofdeeprepetitivetranscranialmagneticstimulationdrtmsagainstmedicalrefractorysymptomsinparkinsonsyndromesfirstgermanrealworlddatawithaspecifich5coil |